CatalystWireBeta

AGM Statement

In brief · summary, not quotable

No summary for this filing – the full text is below.

Full announcement

Select text to share a quote on X · sign in to keep highlights & notes in your NIOX notes

Oxford, UK - 22 May 2024: NIOX Group plc (AIM: NIOX), a medical device company focused on point of care asthma diagnosis and management, is holding its Annual General Meeting today at the Hayakawa Building, Edmund Halley Road, Oxford Science Park. Oxford OX4 4GB.

Trading Update

We are pleased to report that our business has continued to perform strongly in the year to date, in line with management expectations.

In January 2024, NIOX settled returns claims amounting to £0.4m in relation to the discontinued business. The unaudited cash balance as at 30 April 2024 was £23.7m (31 December 2023: £19.9m), with no bank borrowings.

NIOX expects to give a trading update in relation to the six months ended 30 June 2024 around the middle of July.

Cleaned text: letterheads, contacts and legal notices removed. View the original announcement ↗ · Company filings. Not investment advice.

Share this quote

Quote card
Post on X WhatsApp Download image

The link opens this announcement with the quote highlighted. Quotes are checked against the original text.

Add a note